Alberto Farolfi

10PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPacific Peoples youth and familyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 16, 2026
PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study.

|Sep 30, 2026
Quality of life in first-line trials for endometrial cancer: A systematic review.

|Feb 26, 2025
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors.

Alberto Farolfi, Daniela Montanari, Chiara Casadei

|Nov 09, 2024
Treatment Strategies for Advanced Endometrial Cancer According to Molecular Classification.

Valentina Tuninetti, Alberto Farolfi, Chiara Rognone

|Dec 23, 2022
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.

Giorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi

|May 14, 2022
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.

Vincenza Conteduca, Chiara Casadei, Emanuela Scarpi

Pageof 2

Frequent Collaborators

5 joint publications

Ugo De Giorgi

3 joint publications

Vincenza Conteduca

3 joint publications

Giorgia Gurioli

3 joint publications

Giuseppe Schepisi